Devices › Catheter, intravascular, therapeutic, long-term greater than 30 days
Device brand name · Chronic catheters
Broviac CV Catheter, Single-Lumen, 4.2F: medical device reports filed with FDA
206 reports name it, 2020–2026. Manufacturer given most often on reports: C R Bard Basd -3006260740. Product code LJS.
- 206
- device reports naming the brand
- 0% of all MAUDE reports · about 33 a year
- 29
- reports, 12 months to August 2026
- 36 in the 12 months before
- 89.8%
- classified as malfunction
- 81.1% across the product code
- 0.5%
- classified as death, as reported
- 1 reports · not verified by FDA
FDA's MAUDE database holds 206 reports that name the brand "Broviac CV Catheter, Single-Lumen, 4.2F" (chronic catheters), received between April 2020 and August 2026; the manufacturer given most often on reports is C R Bard Basd -3006260740. Spellings of one product vary from report to report.
29 reports arrived in the 12 months to August 2026, down 19% from 36 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (89.8%), injury (9.7%) and death (0.5%); across all catheter, intravascular, therapeutic, long-term greater than 30 days reports (product code LJS) death is recorded in 0.3% and malfunction in 81.1%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are fracture (60.7%), fluid/blood leak (20.4%) and stretched (19.9%). The patient problems coded most often are appropriate clinical signs, symptoms and conditions term/code not available, extravasation and skin erosion. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 37,016 reports carrying product code LJS. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Fracturea broken bone | 125 | 60.7% | 4.7% |
| Fluid/blood leak | 42 | 20.4% | 30.1% |
| Stretched | 41 | 19.9% | 0.5% |
| Material protrusion/extrusion | 31 | 15% | 0.3% |
| Material separation | 28 | 13.6% | 2.3% |
| Burst container or vessel | 21 | 10.2% | 0.6% |
| Difficult to flush | 13 | 6.3% | 0.5% |
| Obstruction of flow | 12 | 5.8% | 1% |
| Deformation due to compressive stress | 10 | 4.9% | 0.8% |
| Expulsion | 10 | 4.9% | 0.2% |
| Material puncture/hole | 9 | 4.4% | 1.3% |
| Material discolored | 6 | 2.9% | 0.1% |
| Air/gas in device | 5 | 2.4% | 0.1% |
| Breakthe device broke | 4 | 1.9% | 11.5% |
| Detachment of device or device componentpart of the device came off | 4 | 1.9% | 1.7% |
| Loosening of implant not related to bone-ingrowth | 4 | 1.9% | 0.1% |
| Loss of or failure to bond | 4 | 1.9% | 0.5% |
| Material integrity problema problem with the device material | 4 | 1.9% | 0.4% |
| Migrationthe device moved from where it was placed | 4 | 1.9% | 0.3% |
| Physical resistance/sticking | 4 | 1.9% | 0.6% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Appropriate clinical signs, symptoms and conditions term/code not available | 10 | 4.9% |
| Extravasation | 4 | 1.9% |
| Skin erosion | 3 | 1.5% |
| Bacterial infectiona bacterial infection | 1 | 0.5% |
| Cardiac perforation | 1 | 0.5% |
| Embolism/embolus | 1 | 0.5% |
| Erythemaskin redness | 1 | 0.5% |
| Fever | 1 | 0.5% |
| Hemorrhage/blood loss/bleeding | 1 | 0.5% |
| Scar tissue | 1 | 0.5% |
| Sepsisa severe body-wide response to infection | 1 | 0.5% |
| Swelling/ edema | 1 | 0.5% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Broviac CV Catheter, Single-Lumen, 4.2F | Product code LJS | All MAUDE reports |
|---|---|---|---|
| Reports | 206 | 37,016 | 26,136,888 |
| Share of that pool | — | 0.6% | 0% |
| Classified as death, per 1,000 reports | 5 | 3 | 9 |
| Classified as injury | 9.7% | 16.8% | 36.2% |
| Classified as malfunction | 89.8% | 81.1% | 62.3% |
| Filed by the manufacturer | 100% | 92.9% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code LJS
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| PowerPICC | 856 | 577 | 0.1% |
| Groshong Nxt Clearvue 4f Single-Lumen Basic Tray With Safety Introducer | 774 | 0 | 0.1% |
| Bard PICC | 733 | 84 | 0% |
| PowerPICC SOLO2, 3CG | 692 | 137 | 0% |
| PowerPICC SOLO2 | 680 | 488 | 0% |
| Groshong Nxt Clearvue 4f Single-Lumen Picc Basic Tray With Microintroducer | 439 | 0 | 0.5% |
| Groshong CLEARVUE | 419 | 415 | 0% |
| Groshong NXT ClearVue | 396 | 150 | 0% |
| Groshong Nxt Clearvue 4f Single-Lumen Picc Basic Tray | 377 | 0 | 0.3% |
| Powerpicc 3cg | 341 | 18 | 0% |
| Nutriline | 328 | 60 | 0.6% |
| Premicath | 338 | 54 | 3.6% |
| Powerpicc Solo Catheter With Sherlock 3cg Tps Stylet 4f Full Tray | 309 | 0 | 0% |
| Powerpicc Solo Catheter With Sherlock 3cg Tip Positioning System Tps Stylet 4f | 264 | 0 | 0% |
| Vaxcel Pasv Picc | 286 | 0 | 0.7% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Broviac CV Catheter, Single-Lumen, 4.2F reports
How many FDA reports name Broviac CV Catheter, Single-Lumen, 4.2F?
206 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 29 in the latest 12 months.
What kinds of events are reported?
malfunction (89.8%), injury (9.7%) and death (0.5%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
fracture (60.7%), fluid/blood leak (20.4%), stretched (19.9%), material protrusion/extrusion (15%) and material separation (13.6%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Broviac CV Catheter, Single-Lumen, 4.2F was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.